Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
57,859,241
-
Total 13F shares
-
14,933,469
-
Share change
-
+14,931,240
-
Total reported value
-
$208,514,000
-
Price per share
-
$14.02
-
Number of holders
-
44
-
Value change
-
+$208,482,958
-
Number of buys
-
43
Institutional Holders of Arcellx, Inc. - COMMON STOCK (ACLX) as of Q1 2022
As of 31 Mar 2022,
Arcellx, Inc. - COMMON STOCK (ACLX) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,933,469 shares.
The largest 10 holders included
Novo Holdings A/S, SUVRETTA CAPITAL MANAGEMENT, LLC, AJU IB Investment Co., Ltd., CITADEL ADVISORS LLC, Clough Capital Partners L P, Samsara BioCapital, LLC, Soleus Capital Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., and VANGUARD GROUP INC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.